Individual and institutional investors, advisors, and analysts are welcome to attend
SINGAPORE, Oct. 06, 2025 – Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical and biotechnology enterprise focused on the development and commercialization of products for chronic wound management, infertility, and cosmeceuticals for the health and beauty sector, today announced that its management team, including Chief Executive Officer, David Quek, will deliver a presentation at the Skyline Signature Series™ on Wednesday, October 8, 2025, at 11:00 AM ET.
This event will be an interactive online session held live, during which investors will have the opportunity to pose questions to the Company in real-time. Pre-registration is mandatory for all investors.
| Event: | Skyline Signature Series™ |
| Date: | Wednesday, October 8, 2025 |
| Time: | 11:00 AM ET |
| Registration: |
ABOUT THE SKYLINE SIGNATURE SERIES™
The Skyline Signature Series offers public companies a practical and efficient platform to share their narrative with a varied group of financial experts via live virtual presentations. Participants from our financial community are meticulously selected and validated by Skyline Corporate Communications Group, LLC (SCCG). To ensure presenters engage with a high-caliber, knowledgeable, and broad audience of financial professionals, each attendee is required to register and undergo individual vetting by SCCG.
Cuprina Holdings (Cayman) Limited will remunerate SCCG for the investor relations services it provides concerning the Company’s securities. For details, please consult the 17(b) Disclaimer and Disclosure Statement available at this link:
About Skyline Corporate Communications Group, LLC
Skyline Corporate Communications Group, LLC, operating from offices in Boston and New York City, functions as an investor relations and corporate communications agency. It offers strategic messaging and investor communications advisory services to publicly traded corporations. Skyline aids companies within the financial markets and investment community by skillfully conveying their corporate message and highlighting their competitive strengths. Our team has collaborated with numerous U.S.-listed public companies globally, spanning various industries and market capitalizations. We possess expertise in shareholder activism and crisis communications, and also assist late-stage private companies in their preparations for entering the public market.
For additional information on Skyline CCG, please visit:
About Cuprina Holdings (Cayman) Limited
Cuprina is a biomedical and biotechnology enterprise headquartered in Singapore, committed to the innovation and market introduction of advanced products for chronic wound care, and is also active in the health and beauty industries. Our proficiency in biomedical research enables us to pinpoint and employ naturally sourced materials to create wound care products as medical devices that adhere to global standards. Further information is available at https:// .
FORWARD-LOOKING STATEMENTS
This press release contains certain statements concerning future expectations, projected plans, and anticipated prospects, along with any other declarations about non-historical matters, which may be deemed “forward-looking statements” under the Private Securities Litigation Reform Act of 1995. Such statements encompass, but are not confined to, those pertaining to the projected trading commencement and closing dates. Terms such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would,” and analogous phrases serve to identify forward-looking statements, though their absence does not preclude a statement from being forward-looking. Actual outcomes could materially diverge from those suggested by such forward-looking statements due to various significant factors, including: market condition uncertainties, whether the public offering concludes on the projected terms or at all, and other elements detailed within the “Risk Factors” section of the preliminary prospectus lodged with the SEC. For these and other reasons, investors are advised against placing undue reliance on any forward-looking statements within this press release. All forward-looking statements in this press release are valid only as of its publication date, and Cuprina Holdings (Cayman) Limited expressly renounces any commitment to revise or update any forward-looking statement, whether owing to new data, subsequent events, or otherwise, except where legally mandated.
Cuprina Holdings (Cayman) Limited Investor Contact
Investor Relations
c/o Blk 1090 Lower Delta Road #06-08
Singapore 169201
+65 8512 7275
Email:
For Investor Relations Inquiries:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email:
